Royal Bank of Canada’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-3,615
| Closed | -$137K | – | 7337 |
|
|
2021
Q1 | $137K | Buy |
3,615
+1,370
| +61% | +$51.9K | ﹤0.01% | 4750 |
|
|
2020
Q4 | $38K | Buy |
2,245
+264
| +13% | +$4.47K | ﹤0.01% | 5227 |
|
|
2020
Q3 | $10K | Buy |
1,981
+30
| +2% | +$151 | ﹤0.01% | 5444 |
|
|
2020
Q2 | $12K | Sell |
1,951
-357
| -15% | -$2.2K | ﹤0.01% | 5309 |
|
|
2020
Q1 | $5K | Sell |
2,308
-2,193
| -49% | -$4.75K | ﹤0.01% | 5571 |
|
|
2019
Q4 | $20K | Buy |
4,501
+2,540
| +130% | +$11.3K | ﹤0.01% | 5260 |
|
|
2019
Q3 | $7K | Buy |
1,961
+1,261
| +180% | +$4.5K | ﹤0.01% | 5289 |
|
|
2019
Q2 | $4K | Sell |
700
-250
| -26% | -$1.43K | ﹤0.01% | 5499 |
|
|
2019
Q1 | $13K | Buy |
950
+221
| +30% | +$3.02K | ﹤0.01% | 5033 |
|
|
2018
Q4 | $7K | Sell |
729
-959
| -57% | -$9.21K | ﹤0.01% | 5246 |
|
|
2018
Q3 | $23K | Sell |
1,688
-464
| -22% | -$6.32K | ﹤0.01% | 5004 |
|
|
2018
Q2 | $34K | Buy |
2,152
+282
| +15% | +$4.46K | ﹤0.01% | 4740 |
|
|
2018
Q1 | $32K | Buy |
1,870
+801
| +75% | +$13.7K | ﹤0.01% | 4656 |
|
|
2017
Q4 | $23K | Sell |
1,069
-2,154
| -67% | -$46.3K | ﹤0.01% | 4811 |
|
|
2017
Q3 | $132K | Buy |
3,223
+2,380
| +282% | +$97.5K | ﹤0.01% | 4108 |
|
|
2017
Q2 | $25K | Sell |
843
-7,487
| -90% | -$222K | ﹤0.01% | 4723 |
|
|
2017
Q1 | $302K | Buy |
8,330
+2,357
| +39% | +$85.5K | ﹤0.01% | 3454 |
|
|
2016
Q4 | $299K | Sell |
5,973
-7,932
| -57% | -$397K | ﹤0.01% | 3503 |
|
|
2016
Q3 | $730K | Buy |
13,905
+12,905
| +1,291% | +$678K | ﹤0.01% | 2760 |
|
|
2016
Q2 | $41K | Buy |
+1,000
| New | +$41K | ﹤0.01% | 4517 |
|
|
2015
Q4 | – | Sell |
-964
| Closed | -$15K | – | 6091 |
|
|
2015
Q3 | $15K | Buy |
+964
| New | +$15K | ﹤0.01% | 5101 |
|